Risk factor
Considerable default risk
Profitability factor
Favourable analyst view
About
Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also offers EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems;...
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is fairly valued on P/E, reasonably pr
Target Price
The average target price of VITR.ST is 170 and suggests 84% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell